MiniMed Group MMED 深 沪
已收盘 08-07 16:00:00 美东时间
19.60
+1.180
+6.41%
华盛通- 最 高19.76
- 今 开18.37
- 成交量 162.55万股
- 最 低 18.1866
- 昨 收 18.42
- 总市值 0
- 52周最高 20.4823
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 10.65
- 委 比 96.51%
- 总股本 --
- 历史最高 20.4823
- 量 比 0
- 振 幅 8.54%
- 历史最低 10.65
- 每 手 1
- 风险率 2.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MiniMed Group Announces Health Canada License New Software For MiniMed 780G System
MiniMed Group, Inc. ((MiniMed, NASDAQ:MMED), a global leader in insulin delivery, announced Health Canada has licensed new software for the MiniMed™ 780G system, marking a meaningful step forward in diabetes care
04-28 21:09
Medtronic Reports Cybersecurity Breach, Says No Impact On Patients Or Operations
On April 24, 2026, Medtronic plc ("Medtronic"), the parent company of MiniMed Group, Inc. ("MiniMed"), announced that an unauthorized third party had accessed data in certain of Medtronic's information technology ("IT")
04-27 20:15
Goldman Sachs' 2 Favorite Under-the-Radar Stocks
Goldman Sachs calls Minimed Group a compelling play on the diabetes market and a potentially profitable stock, with a target price of $24. MiniMed produces insulin pump platforms and continuous glucose monitoring technologies, and recently gained FDA approval for its next-generation insulin pump. The global diabetes market is expected to grow significantly, making MiniMed a promising investment opportunity.
04-18 00:22
Diabetes Focused MiniMed Recovery Story Builds As Pipeline Improves
MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising competition and past share losses.
04-01 22:15
William Blair Initiates Coverage On Minimed Group with Outperform Rating
William Blair analyst Steven Lichtman initiates coverage on Minimed Group (NASDAQ:MMED) with a Outperform rating.
04-01 04:26
